Aptose Biosciences Inc.·4

Jan 20, 5:18 PM ET

Rice William G. 4

4 · Aptose Biosciences Inc. · Filed Jan 20, 2022

Insider Transaction Report

Form 4
Period: 2022-01-18
Rice William G.
DirectorChair, President & CEO
Transactions
  • Award

    Employee Option Grant

    2022-01-18+700,000700,000 total
    Exercise: $1.34Exp: 2032-01-17Common Shares (700,000 underlying)
Footnotes (1)
  • [F1]Fifty percent (50%) of the options vest on 1/18/2023; the remaining 50% vest as follows: 1/3 on 1/18/2024; 1/3 on 1/18/2025; and 1/3 on 1/18/2026.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4